Inhibiting the assembly of protein-protein interfaces.

Protein-protein association is found throughout mechanisms of cellular growth and differentiation, and viral replication. Inhibiting the assembly of protein complexes, therefore, presents itself as a novel means of inhibition for a wide variety of cellular and viral events. Peptides and small molecules that modify the overall quaternary structure of a selection of receptor-ligand interactions and oligomeric viral enzymes have been developed recently.

[1]  The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant , 1996, FEBS letters.

[2]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[3]  Thomas Rawson,et al.  From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione Scaffold , 1994 .

[4]  Y. Nakabeppu,et al.  A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity , 1991, Cell.

[5]  C. Heldin,et al.  Dimerization of cell surface receptors in signal transduction , 1995, Cell.

[6]  T. Gadek,et al.  Structural studies of potent constrained RGD peptides , 1992 .

[7]  J. Kahn,et al.  HIV-1 protease inhibitors. A review for clinicians. , 1997 .

[8]  M. Mueckler,et al.  Molecular biology of receptors and transporters : receptors , 1992 .

[9]  H. Hamm,et al.  Arrestin-rhodopsin interaction. Multi-site binding delineated by peptide inhibition. , 1994, The Journal of biological chemistry.

[10]  L. Babe,et al.  Inhibition of HIV protease activity by heterodimer formation. , 1991, Biochemistry.

[11]  H. Hamm,et al.  The Carboxyl Terminus of the γ-Subunit of Rod cGMP Phosphodiesterase Contains Distinct Sites of Interaction with the Enzyme Catalytic Subunits and the α-Subunit of Transducin (*) , 1995, The Journal of Biological Chemistry.

[12]  R. Goody,et al.  Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. , 1994, The Journal of biological chemistry.

[13]  M. Bouziane,et al.  A synthetic peptide from the human immunodeficiency virus type-1 integrase exhibits coiled-coil properties and interferes with the in vitro integration activity of the enzyme. Correlated biochemical and spectroscopic results. , 1996, European journal of biochemistry.

[14]  I. Brooks,et al.  Specific inhibition of herpes simplex virus DNA polymerase by helical peptides corresponding to the subunit interface. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Coen,et al.  The extreme C terminus of herpes simplex virus DNA polymerase is crucial for functional interaction with processivity factor UL42 and for viral replication , 1993, Journal of virology.

[16]  W Schramm,et al.  The inhibition of human immunodeficiency virus proteases by 'interface peptides'. , 1996, Antiviral research.

[17]  W Gibson,et al.  Structure and assembly of the virion. , 1996, Intervirology.

[18]  S. Jones,et al.  Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Steitz,et al.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. , 1992, Science.

[20]  H. Hamm,et al.  Potent Peptide Analogues of a G Protein Receptor-binding Region Obtained with a Combinatorial Library (*) , 1996, The Journal of Biological Chemistry.

[21]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[22]  W. Stites,et al.  Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis , 1997 .

[23]  M. Garneau,et al.  A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo , 1994, Nature.

[24]  Harold Weintraub,et al.  The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.

[25]  R. Heinrikson,et al.  Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. , 1991, The Journal of biological chemistry.

[26]  Carl Frieden.  Protein-protein interaction and enzymatic activity. , 1971, Annual review of biochemistry.

[27]  R. Zutshi,et al.  TARGETING THE DIMERIZATION INTERFACE OF HIV-1 PROTEASE: INHIBITION WITH CROSS-LINKED INTERFACIAL PEPTIDES , 1997 .

[28]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[29]  I. Weber,et al.  Comparative analysis of the sequences and structures of HIV‐1 and HIV‐2 proteases , 1991, Proteins.